Lactacystin Induces Apoptosis in Resistant CLL Lymphocytes
Author Information
Author(s): J Delic, P Masdehors, S Omura, J-M Cosset, J Dumont, J-L Binet, H Magdelenat
Primary Institution: Institut Curie, Paris
Hypothesis
Can the proteasome inhibitor lactacystin sensitize chemo- and radioresistant chronic lymphocytic leukaemia lymphocytes to apoptosis?
Conclusion
Lactacystin can trigger apoptosis in resistant CLL lymphocytes, making them sensitive to TNF-a treatment.
Supporting Evidence
- Lactacystin induced apoptosis in 55% to 85% of resistant CLL lymphocytes.
- Normal lymphocytes showed only 7% to 9% apoptosis with lactacystin.
- Resistant CLL lymphocytes were unable to activate apoptosis upon irradiation.
Takeaway
Lactacystin helps sick blood cells die when they usually don't, which could help treat some cancer patients.
Methodology
Human lymphocytes were isolated from normal and leukaemic donors, treated with lactacystin, irradiated, and assessed for apoptosis using fluorescence microscopy.
Limitations
The study primarily focuses on a specific subset of CLL patients, which may limit generalizability.
Participant Demographics
25 CLL patients, including 2 resistant and 23 sensitive to treatment.
Want to read the original?
Access the complete publication on the publisher's website